News for hackers. Stuff that matters.

A comment on Third member of U.S. FDA advisory panel resigns over Alzheimer’s drug approval. Parent comment

Re:Third member of U.S. FDA advisory panel resigns over Alzh... by thesausageking on Friday June 11, 2021 @11:05AM (#27474359)
The big question is will insurance companies and CMS pay for it, and that's not up to the FDA. That debate is occurring right now and will likely create new precedents.
[ Parent | on HN ]

There are no comments on this comment yet.